Tumor Necrosis Factor-associated Palmoplantar Pustular Psoriasis Treated with Interleukin 6 Blocker

被引:16
作者
Younis, Said [1 ]
Rimar, Doron [1 ,2 ]
Slobodin, Gleb [1 ,2 ]
Rosner, Itzhak [1 ,2 ]
机构
[1] Bnai Zion Med Ctr, IL-31048 Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Haifa, Israel
关键词
THERAPY; SKIN;
D O I
10.3899/jrheum.120304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2055 / 2057
页数:3
相关论文
共 11 条
[1]  
Fujishima S, 2010, ARCH DERMATOL RES, V302, P499, DOI 10.1007/s00403-010-1033-8
[2]  
Galadari I, 2005, Eur Ann Allergy Clin Immunol, V37, P63
[3]   INTERLEUKIN-6 IS EXPRESSED IN HIGH-LEVELS IN PSORIATIC SKIN AND STIMULATES PROLIFERATION OF CULTURED HUMAN KERATINOCYTES [J].
GROSSMAN, RM ;
KRUEGER, J ;
YOURISH, D ;
GRANELLIPIPERNO, A ;
MURPHY, DP ;
MAY, LT ;
KUPPER, TS ;
SEHGAL, PB ;
GOTTLIEB, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6367-6371
[4]  
Murakata H, 1999, ACTA OTO-LARYNGOL, V119, P384
[5]  
Nakamura Takehiko, 1993, Journal of Dermatology (Tokyo), V20, P763
[6]   Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis [J].
Papp, Kim A. ;
Leonardi, Craig ;
Menter, Alan ;
Ortonne, Jean-Paul ;
Krueger, James G. ;
Kricorian, Gregory ;
Aras, Girish ;
Li, Juan ;
Russell, Chris B. ;
Thompson, Elizabeth H. Z. ;
Baumgartner, Scott .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) :1181-1189
[7]   Skin Manifestations Induced by TNF-Alpha Inhibitors in Juvenile Idiopathic Arthritis [J].
Pontikaki, Irene ;
Shahi, Edit ;
Frasin, Lucretia Adina ;
Gianotti, Raffaele ;
Gelmetti, Carlo ;
Gerloni, Valeria ;
Meroni, Pier Luigi .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 42 (02) :131-134
[8]   Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].
Reich, K ;
Nestle, FO ;
Papp, K ;
Ortonne, JP ;
Evans, R ;
Guzzo, C ;
Li, S ;
Dooley, LT ;
Griffiths, CEM .
LANCET, 2005, 366 (9494) :1367-1374
[9]  
Roux CH, 2007, J RHEUMATOL, V34, P434
[10]   Psoriasis induced by anti-tumor necrosis factor therapy - A paradoxical adverse reaction [J].
Sfikakis, PP ;
Iliopoulos, A ;
Elezoglou, A ;
Kittas, C ;
Stratigos, A .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2513-2518